• TGOD is expanding into the global organic-hemp CBD market with its Global Strategic Hemp Division; the global CBD market is forecast to reach $22 billion in three years
• The company’s flagship Quebec facility received organic certification from Pro-Cert; the site is slated to reach more than 1.3 million square feet
• TGOD plans to enter the U.S. hemp-CBD beverage market through existing partnerships

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is entering the global hemp-CBD market by debuting its Global Strategic Hemp Division. The move will leverage the company’s expertise in the European hemp-CBD market across its established network of international partners (http://ibn.fm/DtLB0).

TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to provide an advantage to market entry for TGOD.

“Our team has years of direct hands-on experience in the CBD space,” TGOD CEO Brian Athaide stated in a news release (http://ibn.fm/RZ0oF). “We are excited to use this advantage to execute on a fast-moving market expansion strategy.”

That strategy includes several initiatives, including expansion in Canada, Germany, Jamaica, Mexico, Poland and the United States. For its entry into the U.S. market, TGOD has developed a suite of hemp-CBD products, including CBD-infused beverages. The company’s approach enables TGOD to enter the American hemp-CBD market quickly and with a capital-light business model.

TGOD has also received organic certification from Pro-Cert for its Valleyfield, Quebec, facility. TGOD anticipates that, when completed, that location will reach 1.3 million square feet and become the largest organic cannabis greenhouse in the world (http://ibn.fm/3a20h). The company already has certified organic growing facilities in Europe and Canada.

TGOD noted that Pro-Cert’s certification programs are ISO 17065 compliant and accredited, offering global recognition and international access to the brands and products it certifies.

Toronto-based TGOD is a premium, global, organic-cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. Through wholly owned subsidiary HemPoland, TGOD distributes premium hemp-CBD oil in the European Union.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• The shifting retail industry is creating new opportunities in direct-selling
• Remote employment and work-from-home positions are projected to make up the majority of the U.S. workforce by 2027
• The company is focused on elevating entrepreneurs with much-needed resources in the ever-growing global direct-selling market

A quick search of the retail industry suggests that the sector is dying, as stores such as Payless, Walgreens, JCPenny, Victoria Secret and more announce closures. However, a closer look reveals that the industry is not dying; it is merely changing. People are skipping crowded malls and shops and opting for the ease of e-commerce and the comfort of direct-selling. According to Statista, the direct-selling market brought in $64 billion in the Americas, with wellness products leading the way with 33.8 percent of total industry sales. An estimated 20.5 million people are involved in direct-selling in the United States, marking a 31 percent increase over a five-year period (http://ibn.fm/dZ7mZ).

The United States is also experiencing a shift toward entrepreneurship and working remotely. Companies specializing in the direct-selling industry, such as Sharing Services Global Corporation (OTCQB: SHRG), are ready for the influx. According to a comprehensive study by Upwork and Freelancers Union, freelancers are projected to make up the majority of the U.S. workforce by 2027 (http://ibn.fm/6sWZq). Freelancing is attractive because it offers individuals freedom to choose their own hours and work locations. However, the option also comes with challenges, such as a lack of health care, sick days and vacation.

SHRG is working to make direct-selling more appealing to the entrepreneur than freelancing. The company is doing this by successfully providing access to much-needed benefits while still offering the freedom of schedule and location. The company coined the term elepreneurs to represent its mission to elevate the lives of its independent distributors through products and services.

Individuals with an entrepreneurial drive who are looking into the direct-selling industry will find professionalism at every turn. The company provides home-based entrepreneurs in the U.S. and others countries with access to insurance, wholesale travel, wellness products, live and online seminars and training events, and unique compensation and reward programs. The company offers a wide range of products and services catered to today’s consumer. This approach helps to generate 100 percent organic growth.

SHRG has identified four specific keys to success that it has continued to build on since launching Elepreneurs and Elevacity Global in December 2017:

1. Attract and retain driven entrepreneurs and shape how home-based Elepreneurs succeed;
2. Continue to expand its holdings portfolio;
3. Rely on the expert guidance of a proven core leadership team; and
4. Capitalize on the forecast growth of the direct-selling industry.

The company’s competitive advantage lies in its wellness products, which are scientifically formulated to stimulate happiness, as well as a unique shared compensation model that creates loyalty and rapid organic growth. By empowering Elepreneurs with freedom, choice and support, SHRG and its subsidiaries are well positioned in an ever-growing global direct-selling market. In the last few months alone, SHRG has grown by thousands of independent sales representatives.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• On July 2, PLUS warrants and debentures began trading on the Canadian Securities Exchange under ticker symbols ‘PLUS.DB’ and ‘PLUS.WT’
• The warrants and debentures were part of a brokered private placement that closed in February 2019, raising gross proceeds of C$25 million
• Plus Products is a San Mateo, California-based manufacturer and marketer of cannabis food products; it has grown from its California base into Nevada

Plus Products Inc.’s (CSE: PLUS) (OTCQX: PLPRF) debentures and warrants from its brokered private placement that closed February 28, 2019, were listed, beginning July 2, on the Canadian Securities Exchange under ticker symbols ‘PLUS.DB’ and ‘PLUS.WT’ (http://ibn.fm/GpEOX). The warrants and debentures were part of a private placement that raised C$25 million, with the funds to be used for working capital and other general corporate purposes.

The private placement of unsecured convertible note units closed on February 28 (http://ibn.fm/yxOqU). The brokered private placement of 25,000 units of the company at a price of C$1,000 per unit consisted of one unsecured convertible debenture having the principal amount of C$1,000 and 77 subordinate voting share purchase warrants of the company.

Every debenture accrues interest at eight percent per year, payable semiannually in arrears until the February 21, 2021, maturity date. They are also convertible into subordinate voting shares at C$6.50 per conversion share starting September 28, 2019. The debentures are unsecured obligations of the company.

Each warrant entitles the holder to acquire one subordinate voting share at a C$8 exercise price per warrant share until February 28, 2024. If exercised during the one-year period from February 28, 2019, the warrant shares will be subject to a 365-day contractual hold from February 28, 2019.

San Mateo, California-based PLUS is a cannabis-infused branded products manufacturer selling to regulated medicinal and adult-use recreational markets in its home-base market of California and Nevada. PLUS is focused on building the largest cannabis brand by growing organically and through acquisitions.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• City View Green Holdings Inc. and Budd Hutt Inc. recently announced an agreement to acquire eight retail cannabis store locations in Alberta
• Investor Quinsam Capital provided an initial investment of $1.1 million as part of a loan arrangement with Budd Hutt
• Budd Hutt plans to establish a flagship location in Alberta to serve as a showpiece for the future of its proposed national retail chain

City View Green Holdings Inc. (CSE: CVGR), a vertically integrated cannabis company, recently announced an exciting development occurring with retail partner Budd Hutt. The latter has entered into an agreement to significantly expand its footprint in the Canadian retail cannabis marketplace. Budd Hutt owns a 19.9 percent stake in City View.

Budd Hutt plans to initially enter the Canadian retail cannabis marketplace through Alberta and intends to acquire eight pre-license retail cannabis store locations in the Alberta market. These stores have already obtained the appropriate regulatory approvals and are waiting on final approval from Alberta Gaming, Liquor and Cannabis (AGLC). On receipt of AGLC approval, all of the stores will be finished, with the initial five retail store locations opening first. The company plans to establish a flagship location in Alberta that will serve as a showpiece for the future of the proposed national retail chain. AGLC licensing for these locations is expected before year’s end (http://ibn.fm/8mSBl).

As a part of a loan arrangement with Budd Hutt, Quinsam Capital has provided an investment of $1.1 million. Quinsam Capital CEO Roger Dent spoke to the lucrative potential of this arrangement in a news release, stating, “We think that Budd Hutt has the potential to be one of the winners as the Canadian cannabis retail marketplace evolves. We look forward to working with the teams at Budd Hutt and City View Green to help make this company a success.”

Leaders with both Budd Hutt and City View Green also described the impact this expansion will have on their respective companies. Budd Hutt CEO Craig Belcher noted that these acquired retail assets could “become key building blocks for Bud Hutt in the Canadian retail cannabis marketplace.” These retail acquisitions are fully in line with the company’s national strategy, said Belcher, which also “includes Ontario (post lottery moratorium) and… a yet to be announced national partnership that would add significant premium locations across Canada and would also potentially make Budd Hutt one of Canada’s first national retail cannabis store chains.” Though this national partnership is still in the works, the team at Budd Hutt sees this industry expansion bringing its strategic vision to life.

In a news release, City View Green CEO Ian MacDonald also weighed in on the impact of these retail acquisitions, stating, “This announcement from our retail partner Budd Hutt is incredibly exciting for CVG and its shareholders. Having an aggressive coast to coast retail strategy makes Budd Hutt a truly unique retail business model and adds tremendous value to CVG’s route to market strategy… Congratulations to the Budd Hutt team on this incredible achievement.”

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

• Seasoned life sciences executive Dr. Bin Huang has been appointed to the Geyser board of directors
• Chartered Professional Account Gordon Clissold has been named chief executive officer
• Geyser Brands is entering into a definitive agreement for the acquisition of Solace Management Group, which will broaden the company’s range of CBD- and hemp-based products

Geyser Brands Inc. (TSX.V: GYSR), a leading consumer health care company based in Vancouver, British Columbia, builds health-based hemp CBD consumer products in the worldwide nutraceutical, cosmetics, food & beverage and pet sectors. Recent pivotal appointments to Geyser Brand’s leadership team are expected to strengthen the company’s position and bring valued oversight to its ongoing development, as noted in a news release (http://ibn.fm/ElFjT).

Joining the board of directors is Dr. Bin Huang, a seasoned life sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia. She most recently served as CEO of Emerald Health Therapeutics Inc. and has held senior management roles in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell biology from the University of East Anglia, UK, and an MBA from the University of Toronto, Canada.

“The board of directors are extremely pleased that Dr. Huang has accepted our offer to join our growing company” Brad Kersch, chairman of the board, stated in a news release. “Her depth of experience in life sciences and her leadership demonstrated in the corporate world, particularly in the cannabis industry, will provide unparalleled value and oversight to the company’s development.”

Chartered Professional Accountant Gordon Clissold will take the position of chief financial officer, effective immediately, while Jennifer Hanson was recently named as corporate secretary. Clissold has over 20 years of experience as an operational and financial manager for both public and private companies and is a past president of the Certified General Accountants of BC.

“Gordon brings tremendous experience and added bench strength in both operational and financial management and we are very pleased he’s agreed to join the Geyser executive team,” Geyser Brands CEO Andreas Thatcher added.

The company also recently announced a significant advancement toward achieving its long-term vision of manufacturing premier CBD products, including tinctures and supplements. According to a news release (http://ibn.fm/pSliY), a coveted Health Canada standard processing license was awarded to the company’s wholly owned licensed producer, 0957102 B.C. Ltd. dba Apothecary Botanicals.

“This is a huge milestone for Geyser Brands and something that we have been working toward for many months,” Thatcher stated in the release. “The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD. It also reflects our business model to focus our licensed producer on delivering scale through manufacturing and distribution. I wish to congratulate the team at Apothecary Botanicals and Geyser for all the hard work in obtaining this license. We are moving forward full steam with our vision and there is plenty more to come in the future.”

An earlier announced strategic acquisition of Solace Management Group Inc. is expected to add to Geyser Brands’ growing portfolio, establishing the company as a leading provider of health-focused CBD and hemp products (http://ibn.fm/yTJVU).

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR

• A joint development agreement signed with Noramco Inc., the world’s largest producer of chemically synthesized cannabinoids and pharmaceutical APIs, is expected to scale the development of Willow’s CBD biosynthesis program
• The collective market for CBD sales in the U.S. is expected to exceed $20 billion by 2024, while the cannabinoid-based pharmaceuticals market may reach $50 billion by 2029
• Synthetic biology is expected to disrupt the cannabinoid industry supply chain, providing access to new and larger markets for CBD and related compounds

Willow Biosciences Inc. (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (APIs) and intermediates, is pursuing the burgeoning CBD market with a world-class partner. Willow recently announced a joint development agreement (JDA) with Noramco Inc., a leading manufacturer of cannabinoids, to collaboratively develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (CBD) (http://ibn.fm/8F330).

The JDA is mutually exclusive and creates an enviable arrangement designed to take advantage of each company’s unique and compelling skillsets, the news release notes. The JDA requires each company to cover its own costs, retain its own intellectual property associated with its own scopes of work and share equally in the gross profits from sales of CBD produced under the agreement.

Together, Willow and Noramco will aim to address the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

“Noramco is a world-class organization with a long history of developing APIs across numerous markets and is the market leader in synthetically produced CBD,” Dr. Joseph Tucker, Willow’s executive chairman, said in a news release. “They are the obvious first choice as a partner to scale the development of our CBD biosynthesis program. Noramco’s global leadership in the production and sales of cannabinoids to pharmaceutical companies will naturally lead into manufacturing and sales into additional nonpharmaceutical markets.”

It’s a lucrative market that is generating ample analytical statistics for investors to consider. BDS Analytics forecasts that the collective market for CBD sales is expected to exceed $20 billion in the U.S. by 2024 (http://ibn.fm/wgthy), stating in its report, “We’re witnessing CBD maturing from a cannabis sub-category into a full-blown industry of its own.”

Statista’s Research Department projects that the cannabinoid-based pharmaceutical market in the U.S. will soar from a mere $2 billion in 2020 to $50 billion by 2029 (http://ibn.fm/AEUai). As a technology platform, biosynthesis can provide a low-cost, ultrapure and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD. The work conducted in the JDA between Willow and Noramco has the potential to open new and larger markets for CBD and related compounds.

“The addition of biosynthetic CBD production will augment Noramco’s ability to work with our existing customers and the capacity to address the rapidly increasing market demand for CBD-based APIs and ingredients from pharmaceutical, nutraceutical, consumer packaged goods, beverage and other industry sectors,” Bill Grubb, Noramco’s chief innovation officer and vice president of global business development, said in a news release. “We are excited to be working with the world class team at Willow and are confident in their ability to deliver scalable, CBD-producing strains to Noramco.”

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (THC) and cannabigerol (CBG), as well as certain minor and novel cannabinoids. Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical-grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow believes that its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60 percent less than current chemical synthesis methods and 90 percent less than conventional plant-based extraction methods.

For more information, visit the company’s website at www.WillowBio.com

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW

• Lithium demand is seen as being long-term and relentless
• This market dynamic creates favorable conditions for resource development companies like QMC Quantum Minerals
• QMC is already at work to initiate sustainable lithium production at its Irgon Lithium Mine Project

Global lithium demand is anticipated to triple by 2025, driven primarily by expanded lithium-ion battery production for the electric vehicle market. According to a lithium market update, demand for lithium grew by more than 27 percent in 2018 (http://ibn.fm/9fsZn) and is expected to grow at rates above 20 percent in 2019.

Forecasts suggest that lithium demand will continue growing at healthy levels well beyond 2019. Some analysts believe that demand for one million tons per year could be reached much sooner than anticipated. According to Benchmark Mineral Intelligence quoted by Investing News, the achievement of full battery mega-factory capacity will contribute to a lithium demand of 961,351 tons per year in 2023 and over 1.57 million tons in 2028.

QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) is already strategically positioned to supply lithium on the basis of the growing demand. QMC Quantum Minerals engages in the acquisition, exploration and development of natural resource properties. Strategic acquisitions enable the development of high-quality lithium, gold, silver, nickel, zinc and copper deposits.

The company’s current properties are located in the Canadian province of Manitoba – one of the most productive and accessible mining areas in the country, which is insulated from many of the political pressures that threaten non-North American sources. The Irgon Lithium Mine Project is a key part of the company’s portfolio, not only because of the historic resource estimate and the most recent analyses that expand on it, but because of its potential to be in production in a short period of time.

Several factors contribute to the positive projections for the Irgon Project, including easy access to well-developed infrastructure such as the processing facility located at the recently acquired TANCO Mine. Sinomine Resource Group Co. Ltd., based in China, purchased from Cabot Corporation (NYSE: CBT) its Specialty Fluids business (located at the TANCO Mine) for $135 million, including royalties of up to $5 million for lithium products.

In addition, QMC recently received positive assay results from historical drill cores for two of the supplementary Irgon Lithium Mine dikes. These suggest a much higher resource availability than what’s listed in historic estimates for the region. These findings could enable QMC Quantum Minerals to position itself as a leading provider of lithium serving a growing market driven by the rapid expansion of the electric vehicle industry.

Lithium is sometimes referred to as ‘white petroleum’, and it is a finite resource. By 2025, the search for sustainable and green solutions will increase the need for lithium by more than five times the current production levels (http://ibn.fm/6fAgr). Numerous vehicle manufacturers have announced plans to launch multiple electrical vehicle models – one of the new market trends that will have a primary effect on lithium production.

Volkswagen alone has announced more than 70 electric car model launches for the coming decade. Several other primary manufacturers have made similar announcements, as a Forbes report notes.

All indicators suggest an upward trend for lithium. In March 2019, battery capacity deployed worldwide in electric cars nearly doubled on an annual basis (http://ibn.fm/iUlFh). The lithium share per kWh has also expanded. Full electric vehicles are taking market share from hybrid cars, and China alone already has 486 registered electric vehicle manufacturers.

QMC is uniquely positioned to benefit from the growing demand for lithium as it works to initiate production at its Manitoba assets and position itself as a key player and provider on the domestic market. With a strong commitment to creating shareholder value through the strategic acquisition and development of quality prospects in one of Canada’s most productive mining regions, paired with a highly experienced management team, the company stands as a very attractive and lucrative investment opportunity.

For more information, visit the company’s website at www.QMCMinerals.com

NOTE TO INVESTORS: The latest news and updates relating to QMCQF are available in the company’s newsroom at http://ibn.fm/QMCQF

• Organic farming is forecast to grow at a CAGR of 8.4 percent through 2026, fueled by high demand and concerns about the use of traditional agricultural practices
• The organic pesticide market is also expected to expand, at a CAGR of approximately 14.9 percent through 2023
• These market dynamics show that companies like MustGrow Biologics that specialize in biopesticides and biofertilizers could benefit from significant growth opportunities

As the global organic farming market continues growing at a sustainable and consistent rate, new expansion opportunities emerge for organizations such as MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company that develops and commercializes natural biopesticides and bio-fertilizers serving as an alternative to synthetic pesticides and fertilizers typically used by cannabis and fruit and vegetable growers.

According to the ‘Organic Farming Market – Size, Share, Outlook and Opportunity Analysis’ report, the global organic farming market is anticipated to grow at a CAGR of 8.4 percent through 2026 (http://ibn.fm/VSVGi). Europe is expected to account for 25 percent of the growth during the forecast period. Until 2015, North America held the largest market share in the field of organic food production. Other markets are anticipated to start catching up, contributing to dynamic developments and the rapid adoption of new technologies.

Based on this forecast, it’s not surprising to also explore positive predictions for the organic pesticides market. Forecasts suggest that the market will reach $279 billion by 2023, as detailed in an Allied Market Research report (http://ibn.fm/k4cSo). The compound annual growth rate is estimated at 14.9 percent for the period from 2017 to 2023.

North America currently dominates the global biopesticides market, accounting for approximately a third of the market share. Several factors have been fueling growth of the market. The first and most prominent contributor is the heightened demand for organically grown products. In North America, the growth in demand is 13.8 percent. In Europe, it has reached 13.5 percent, and, in the Asia-Pacific region, it has reached 12.1 percent. Growing concerns about the use of traditional commercial pesticides are also driving a switch to biologically-sound, natural and organic-compatible products.

The organic pesticide market is segmented into natural and synthetic products. Natural products have historically accounted for a major share of the global organic pesticides market. Some growth is anticipated in the field of synthetic products, but natural is still likely to dominate.

These forecasts suggest that companies like MustGrow Biologics Corp. will benefit from excellent expansion opportunities in the years to come. MustGrow’s natural biopesticide and biofertilizer are effective and safe, as well as easy to use. The products can be utilized in the production of fruits, vegetables, turf and ornamental industries.

Both the MustGrow biopesticide and biofertilizer are refined from compounds of the mustard plant. These compounds are powerful nematicides, fungicides and pesticides. Research suggests that the MustGrow biopesticide delivers effective pathogen and pest control to ensure plant growth and high yields.

The MustGrow biopesticide has U.S. Environmental Protection Agency (EPA) and Canadian Pest Management Regulatory Agency (PMRA) labels. The product is approved for organic agriculture, allowing for safe and reliable pest and disease control.

To date, MustGrow has carried out over 110 independent third-party field trials on fruit and vegetable crops. The results suggest that MustGrow’s product is 100 percent capable of controlling root-knot nematodes, while delivering 95 percent control of Pythium root rot and 70 percent reduction in Verticillium root severity. As a result, the MustGrow biopesticide has been shown to increase tomato crop yields by 55 percent. The results cement MustGrow’s leading position in the market of unique solutions to help cannabis cultivators and fruit and vegetable growers control pests and crop diseases.

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• CIIX CEO forecast that the company’s sales will reach $11­­­-12 million by 2020 during an interview with Redchip Money Report
• CIIX recently opened a hemp-based CBD product retail store in the Chinese-concentrated area of San Gabriel, California
• The company is geared up to concentrate on financial consultancy and related services targeted at the Chinese community in the United States

Warren Wang, CEO of ChineseInvestors.com Inc. (OTCQB: CIIX), predicted during a recent interview with Redchip Money Report that the company’s sales will reach $11‑12 million by 2020 (http://ibn.fm/KDzDV). Wang further emphasized that though CBD had played an important role in the growth of the company, CIIX offers diverse services that aid in its growth, development and stability.

CIIX offers its Chinese-speaking audience daily investment information through its online information portal, TV and radio shows, podcasts and real-time market commentary. CIIX also conducts online/offline cryptocurrency and blockchain education classes.

ChineseInvestors.com was founded in 1999 and has been primarily engaged in providing financial information and services to the Chinese-speaking investor community in the United States. With its immense knowledge and expertise in the financial realm, CIIX is leveraging the stupendous growth of the CBD products industry, which is expected to reach $20 billion in sales by 2024 (http://ibn.fm/zXA8l). In 2019, the company experienced an increase of 81 percent in revenue, which Wang attributes to CIIX’s hemp sales (http://ibn.fm/Lc4NI). CIIX is a leading Chinese CBD company, catering to four million Chinese-speaking Americans and Canadians.

During the interview, Wang also stated that, with the high spending capacity of Chinese consumers and huge market opportunities in the United States, Asia, and China specifically, CIIX’s sales are expected to double in the next 12 months. More mergers and acquisitions are lined up for the company in both the Chinese and wider Asian markets.

CIIX launched a CBD product-based website, ChineseCBDoil.com, in January 2017, offering industrial hemp-derived products to Chinese-speaking people worldwide. Company headquarters are located in the Chinese-concentrated area of San Gabriel, California, where CIIX opened its first mall popup kiosk on May 1, 2019 (http://ibn.fm/Haqhi). This retail outlet also offers customers hemp-derived and other CBD products.

In addition to its reach into the hemp space, the company’s main focus and core revenue source remains developing and marketing web-based tools designed to provide financial information and investment knowledge to the Chinese-speaking community in America. The company’s original website, ChineseFN.com (http://ibn.fm/CbdZS), has a following of more than 100,000 registered users and 5,000 subscribers.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• Siyata’s UV350 is the world’s first and only dedicated in-vehicle, 4G/LTE-capable smartphone specifically designed to ensure safer communications for first responders and professional fleet drivers
• Target markets for the company’s device include an estimated 10 million commercial trucks on America’s roadways and more than 3.5 million emergency and public safety vehicles
• Siyata Mobile Inc. was named in the Venture Top 50 for 2018

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF), a global developer and provider of cellular communications systems, is responding to a critical need expressed by commercial fleet drivers and their public safety counterparts who need to concentrate on their jobs and not be distracted by antiquated communication systems. Specifically designed to ensure safer communications, Siyata’s Uniden UV350 is the world’s first in-vehicle 4G/LTE smartphone providing crystal clear audio quality via a single unit with built-in, carrier-grade Push-to-Talk, voice, text, video and data applications (http://ibn.fm/6lG4A).

With more than 3.5 million first responder vehicles estimated in the United States alone, an immense market exists for fast, reliable and effective public safety communication. The nation’s pursuit of a dedicated nationwide broadband network for first responders – a critical need made painfully obvious during and after 9/11 – is highlighted in an editorial featuring Siyata Mobile and the First Responder Network Authority (FirstNet) (http://ibn.fm/i4f46).

Siyata Mobile’s FirstNet Ready Uniden UV350 4G/LTE In-Vehicle Device for Public Safety (http://ibn.fm/5DJQs) is designed for the cabin of fire trucks, ambulances and police squad cars, combining the functions of multiple devices into one. It supports the FirstNet band 14 spectrum and gives public safety subscribers access to the dedicated, physically separate FirstNet network core that provides priority during emergencies.

“Drivers who are operating vehicles, whether it is a first responder vehicle or a commercial truck, need to feel safe while communicating important information,” Siyata Mobile CEO Marc Seelenfreund said in a news release. “The demand for a multi-functioning, in-vehicle device remains strong, especially from those who are required to operate vehicles in demanding situations. The UV350 allows drivers to keep their eyes on the road, and hands on the wheel.”

Commercial fleet drivers are also hampered by numerous distractions in cabin vehicles, which can include various communication devices from different vendors, all of which are burdened with multiple monthly voice and data fees. Siyata’s UV350 can effectively solve those issues for the nearly 10 million commercial vehicles in the U.S. with a cost-effective platform that runs on cellular LTE networking, providing global and nationwide coverage (http://ibn.fm/rx5ej).

For more information, visit the company’s website at www.SiyataMobile.com

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF